Earnings History Data for Soligenix (SNGX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Soligenix

Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing products to treat the life-threatening side effects of cancer treatments and serious gastrointestinal diseases where, as well as developing several biodefense vaccines and therapeutics. The Company operates in two reportable segments: BioTherapeutics and BioDefense. The BioTherapeutics business segment intends to develop orBec ? (oral beclomethasone dipropionate, or oral BDP) and other biotherapeutic products, including LPM TM Leuprolide. The BioDefense business segment intends to convert its ricin toxin vaccine and radiation injury programs from early stage development to advanced development and manufacturing. Soligenix, Inc, formerly known as DOR BioPharma, Inc, is headquartered in Princeton, New Jersey.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
10-11-2022	PM	7:30 AM ET (Nov 10)	SNGX	Soligenix	28.00	-0.08	-0.08	0.00	Soligenix GAAP EPS of -$0.08 beats by $0.01, revenue of $0.2M in-line [11/10/2022 8:38 AM]	0.6901	0.02 (3.18%)	0.62	-0.05 (-7.30%)	0.38 - 1.00	75,946	50,000	404
Soligenix GAAP EPS of -$0.08 beats by $0.01, revenue of $0.2M in-line [11/10/2022 8:38 AM] Soligenix Announces Recent Accomplishments And Third Quarter 2022 Financial Results [Nov-10-22 07:30AM]
13-05-2022	PM	7:30 AM ET (May 13)	SNGX	Soligenix, Inc.	18.32	-0.10	-0.06	-0.06	Soligenix GAAP EPS of -$0.10 misses by $0.03, revenue of $0.2M beats by $0.1M [5/13/2022 7:46 AM]	0.4124	0.01 (3.62%)	0.40	0.0 (0.00%)	0.38 - 1.34	107,171	160,000	1,432
Soligenix Announces Recent Accomplishments And First Quarter 2022 Financial Results [May-13-22 07:30AM]
12-11-2021	PM		SNGX	Soligenix, Inc.	38.90	-0.09	-0.13	-0.06	Soligenix EPS beats by $0.03, misses on revenue [11/12/2021 7:51 AM]	0.9151	0.0 (-0.03%)	0.94	0.02 (2.69%)	0.85 - 2.80	269,772	310,000	4,254
Soligenix EPS beats by $0.03, misses on revenue [11/12/2021 7:51 AM] Soligenix Announces Recent Accomplishments And Third Quarter 2021 Financial Results [Nov-12-21 07:30AM]
17-05-2021	PM		SNGX	Soligenix Inc.	35.00	-0.06	-0.11	0.00	Soligenix EPS beats by $0.05, misses on revenue [5/17/2021 8:06 AM]	0.9401	0.05 (5.63%)	0.0	0.0 (0.00%)	0.85 - 2.99	334,498	1,050,000	0
Soligenix EPS beats by $0.05, misses on revenue [5/17/2021 8:06 AM] Soligenix Announces Recent Accomplishments And First Quarter 2021 Financial Results [May-17-21 07:30AM] Village Farms International to Participate in BMO Capital Markets 16th Annual Farm to Market Conference [May-17-21 07:00AM]
30-03-2021	PM	7:00 AM ET (Mar 30)	SNGX	Soligenix, Inc.	49.43	-0.19	-0.09	-0.14	Soligenix EPS misses by $0.10, beats on revenue [3/30/2021 7:30 AM]	1.51	0.02 (1.34%)	1.48	-0.01 (-0.67%)	1.21 - 2.99	530,010	1,290,000	23,988
Soligenix EPS misses by $0.10, beats on revenue [3/30/2021 7:30 AM] Soligenix Announces Recent Accomplishments And Year-End 2020 Financial Results [Mar-30-21 07:00AM]